title: Thalidomide-induced organizing pneumonia.
abstract: Twenty medications are associated with drug-induced organizing pneumonia; however, thalidomide is not listed as a potential causative agent. Thalidomide (Thalomid, Celgene Corp., Summit, NJ), an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, is used for the treatment of multiple myeloma. We report a case of organizing pneumonia in a 58-year-old male with multiple myeloma treated with dexamethasone and thalidomide.
authors.affiliation: Department of Medicine at Madigan Army Medical Center, Fort Lewis, WA, USA. ashley.feaver@us.army.mil
authors.forename: Ashley A
authors.initials: AA
authors.lastname: Feaver
authors.forename: David E
authors.initials: DE
authors.lastname: McCune
authors.forename: Angela G
authors.initials: AG
authors.lastname: Mysliwiec
authors.forename: Vincent
authors.initials: V
authors.lastname: Mysliwiec
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018549:Cryptogenic Organizing Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D020533:Angiogenesis Inhibitors; D007166:Immunosuppressive Agents; D013792:Thalidomide